AU737606B2 - Therapeutically active compositions - Google Patents

Therapeutically active compositions Download PDF

Info

Publication number
AU737606B2
AU737606B2 AU77829/98A AU7782998A AU737606B2 AU 737606 B2 AU737606 B2 AU 737606B2 AU 77829/98 A AU77829/98 A AU 77829/98A AU 7782998 A AU7782998 A AU 7782998A AU 737606 B2 AU737606 B2 AU 737606B2
Authority
AU
Australia
Prior art keywords
component
composition
composition according
unit dosage
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU77829/98A
Other languages
English (en)
Other versions
AU7782998A (en
Inventor
Fiona Kate Gardiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technostics Ltd
Original Assignee
Reckitt Benckiser Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare UK Ltd filed Critical Reckitt Benckiser Healthcare UK Ltd
Publication of AU7782998A publication Critical patent/AU7782998A/en
Application granted granted Critical
Publication of AU737606B2 publication Critical patent/AU737606B2/en
Assigned to RECKITT BENCKISER HEALTHCARE (UK) LIMITED reassignment RECKITT BENCKISER HEALTHCARE (UK) LIMITED Amend patent request/document other than specification (104) Assignors: RECKITT & COLMAN PRODUCTS LIMITED
Assigned to TECHNOSTICS LIMITED reassignment TECHNOSTICS LIMITED Alteration of Name(s) in Register under S187 Assignors: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU77829/98A 1997-06-10 1998-06-08 Therapeutically active compositions Ceased AU737606B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9711962.2A GB9711962D0 (en) 1997-06-10 1997-06-10 Therapeutically active compositions
GB9711962 1997-06-10
PCT/GB1998/001673 WO1998056356A1 (en) 1997-06-10 1998-06-08 Therapeutically active compositions

Publications (2)

Publication Number Publication Date
AU7782998A AU7782998A (en) 1998-12-30
AU737606B2 true AU737606B2 (en) 2001-08-23

Family

ID=10813845

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77829/98A Ceased AU737606B2 (en) 1997-06-10 1998-06-08 Therapeutically active compositions

Country Status (17)

Country Link
US (1) US6201014B1 (https=)
EP (1) EP0988028B1 (https=)
JP (1) JP2002513418A (https=)
KR (1) KR20010013618A (https=)
CN (1) CN1198594C (https=)
AR (1) AR012960A1 (https=)
AT (1) ATE262892T1 (https=)
AU (1) AU737606B2 (https=)
BR (1) BR9809994A (https=)
CA (1) CA2291796C (https=)
DE (1) DE69822822T2 (https=)
GB (3) GB9711962D0 (https=)
HU (1) HUP0004245A2 (https=)
ID (1) ID22878A (https=)
PL (1) PL337337A1 (https=)
WO (1) WO1998056356A1 (https=)
ZA (1) ZA984920B (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790207B2 (en) * 1998-06-04 2004-09-14 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract
US6802841B2 (en) * 1998-06-04 2004-10-12 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
US20110071468A1 (en) * 1998-06-04 2011-03-24 Mederi Therapeutics, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
GB9812426D0 (en) * 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB9925127D0 (en) * 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
WO2001064202A2 (en) * 2000-03-01 2001-09-07 Euro-Celtique S.A. Tramadol for the treatment of functional gastrointestinal disorders
US7192612B2 (en) * 2001-02-22 2007-03-20 Purdue Research Foundation Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
AU2002254007B2 (en) 2001-02-22 2006-09-21 Purdue Research Foundation Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
US6428822B1 (en) 2001-04-03 2002-08-06 Chengzhi Life Science Company, Ltd. Extracts of mixed arctium lappa L., carrot and whole radish for treating hypertension, constipation and detoxification
US6682759B2 (en) * 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
US7198804B2 (en) * 2002-04-12 2007-04-03 Helixir Co., Ltd. Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases
PT1605956E (pt) * 2002-12-18 2016-03-09 Centrexion Therapeutics Corp Administração de capsaicinóides para o tratamento da osteoartrite
US20040156931A1 (en) * 2002-12-18 2004-08-12 Algorx Administration of capsaicinoids
EP1615880A4 (en) * 2003-04-08 2007-03-07 Algorx Pharmaceuticals Inc PREPARATION AND CLEANING OF SYNTHETIC TRANS CAPSAICIN
US20100159000A1 (en) * 2003-11-10 2010-06-24 Lundeen Sr James E Medicine for treating gastrointestinal disorder including fecal incontinence
AT413646B (de) * 2004-04-02 2006-04-15 Hammer Johann Dr Verwendung von capsaicin und/oder capsaicinoiden
US20050277657A1 (en) * 2004-06-15 2005-12-15 Dusan Ninkov Method of protection of biologically active essential oils and pharmaceutical composition for weight control and enhance fat burning in adults, adolescents and children
EA200701131A1 (ru) * 2004-11-24 2007-12-28 Алгоркс Фармасьютикалз, Инк. Гелеобразная препаративная форма капсаициноида и способы её применения
ES2533256T3 (es) 2004-12-28 2015-04-08 Mestex Ag Uso de resiniferatoxina (RTX) para la fabricación de un medicamento para el tratamiento del dolor
US20080103102A1 (en) 2006-10-27 2008-05-01 Bmb Patent Holding Corporation Therapeutic compositions and methods of treatment with capsianoside-type compounds
CN101835500B (zh) * 2007-08-29 2014-05-28 吸附剂治疗学公司 具有可变抗衡离子含量的吸收性聚合物组合物及其制备方法和用途
KR20090047637A (ko) * 2007-11-08 2009-05-13 재단법인서울대학교산학협력재단 커큐민 또는 이의 약학적으로 허용가능한 염을유효성분으로 함유하는 통증 예방 및 치료용 조성물
HUP0700755A2 (en) * 2007-11-26 2009-08-28 Pannonpharma Gyogyszergyar Pharmaceutical compositions containing capsaicionoid and non-steroidal anti-inflammatory drug
US8697155B2 (en) * 2008-07-22 2014-04-15 Mayo Foundation For Medical Education And Research Treatment of obesity and related disorders
US20110200669A1 (en) * 2010-02-15 2011-08-18 Winston Laboratories, Inc. Method and compositions of civamide to treat disease of the intestines
KR101378973B1 (ko) * 2012-04-13 2014-03-28 한미약품 주식회사 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법
CN103027901B (zh) * 2012-12-11 2014-11-12 广东药学院 一种载辣椒素壳聚糖微球肠溶片及其制备方法
US10092528B2 (en) 2013-03-13 2018-10-09 Altria Client Services Llc Application of encapsulated capsaicin and analogues thereof for controlling calorie intake
CA2903493C (en) 2013-03-15 2022-05-31 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
US9289418B2 (en) 2013-03-15 2016-03-22 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
AU2014380905A1 (en) * 2014-01-30 2016-09-08 Omniactive Health Technologies Limited Composition of oily, pungent and odoriferous substances and a process of preparation thereof
RU2697851C2 (ru) 2014-08-13 2019-08-21 Седарс-Синаи Медикал Сентер Антиметаногенные композиции и их применение
EP3277274B1 (en) * 2015-04-01 2024-06-12 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
JP7436622B2 (ja) * 2019-07-18 2024-02-21 ディグニファイ セラピューティクス エルエルシー 排便を誘導するための組成物および方法
PL4135652T3 (pl) * 2020-04-15 2025-03-10 Grünenthal GmbH Kompozycje rezyniferatoksyny
AU2022207425A1 (en) * 2021-01-15 2023-07-06 Dignify Therapeutics, Llc Compositions and methods for inducing defecation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0015334A1 (en) * 1977-08-04 1980-09-17 J.B. Tillott Limited Carminative preparations containing peppermint oil or its active components
EP0149545A2 (en) * 1984-01-16 1985-07-24 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
WO1996040079A1 (en) * 1995-06-07 1996-12-19 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2207705A1 (en) * 1972-11-24 1974-06-21 Marconnet Rene Deodorisation of body odours - by liberation of odoriferous substances in the intestines
US5403868A (en) 1988-12-23 1995-04-04 Sandoz Ltd. Capsaicin derivatives
HU206082B (en) * 1988-12-23 1992-08-28 Sandoz Ag Process for producing capsaicin derivatives and pharmaceutical compositions comprising such compounds
US5063060A (en) 1989-12-19 1991-11-05 Cisco Limited Partnership Compositions and method for treating painful, inflammatory or allergic disorders
DE4137540A1 (de) * 1991-11-14 1993-05-19 Steigerwald Arzneimittelwerk Verwendung von praeparaten der curcuma-pflanzen
US5431914A (en) 1992-04-17 1995-07-11 Adekunle; Michael Method of treating an internal condition by external application of capsaicin without the need for systemic absorption
AU4382693A (en) 1992-05-21 1993-12-13 Jeff J. Staggs Therapeutic uses of pungent botanicals and their related compounds
EP0839037B1 (en) * 1995-07-14 2002-11-13 Sabinsa Corporation Bioprotectant composition, method of use and extraction process of curcuminoids

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0015334A1 (en) * 1977-08-04 1980-09-17 J.B. Tillott Limited Carminative preparations containing peppermint oil or its active components
EP0149545A2 (en) * 1984-01-16 1985-07-24 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
WO1996040079A1 (en) * 1995-06-07 1996-12-19 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids

Also Published As

Publication number Publication date
EP0988028B1 (en) 2004-03-31
ATE262892T1 (de) 2004-04-15
GB9827192D0 (en) 1999-02-03
CA2291796A1 (en) 1998-12-17
GB9711962D0 (en) 1997-08-06
EP0988028A1 (en) 2000-03-29
GB2332147A (en) 1999-06-16
HUP0004245A2 (hu) 2001-08-28
CN1198594C (zh) 2005-04-27
KR20010013618A (ko) 2001-02-26
AR012960A1 (es) 2000-11-22
BR9809994A (pt) 2000-08-01
DE69822822D1 (de) 2004-05-06
CN1259863A (zh) 2000-07-12
PL337337A1 (en) 2000-08-14
ZA984920B (en) 1999-07-01
GB9811819D0 (en) 1998-07-29
WO1998056356A1 (en) 1998-12-17
ID22878A (id) 1999-12-16
CA2291796C (en) 2008-03-25
AU7782998A (en) 1998-12-30
US6201014B1 (en) 2001-03-13
DE69822822T2 (de) 2005-01-13
JP2002513418A (ja) 2002-05-08
GB2332147B (en) 1999-10-27

Similar Documents

Publication Publication Date Title
AU737606B2 (en) Therapeutically active compositions
AU2002318155B8 (en) Solid pharmaceutical formulations comprising modafinil
PL200957B1 (pl) Kompozycja farmaceutyczna celecoxib'u i zastosowanie kompozycji farmaceutycznej
PL194309B1 (pl) Farmaceutyczna postać dawkowana efawirenzu i sposób jej wytwarzania
AU5432401A (en) Oral solid pharmaceutical formulations with ph-dependent multiphasic release
AU2002318155A1 (en) Solid pharmaceutical formulations comprising modafinil
HUT74477A (en) Film coated tablet of paracetamol and domperidone
KR101050015B1 (ko) 위체류약물전달시스템을 이용한 애엽 추출물의 약학조성물및 이를 이용한 서방성 경구용 제제
Gohel Modulation of active pharmaceutical material release from a novel ‘tablet in capsule system’containing an effervescent blend
KR101125361B1 (ko) 모다피닐의 신규한 제약 제제
JP6864970B2 (ja) 胃腸薬組成物
CN105919967A (zh) 一种盐酸阿考替胺制剂及其应用
US9155704B1 (en) More palatable, bioequivalent pharmaceutical composition of carprofen
US20180318228A1 (en) Method for a slow release of drugs from orally dissolving capsules
MXPA99011247A (en) Therapeutically active compositions
KR20170001545A (ko) 모사프리드 서방성 제제 및 모사프리드와 라베프라졸의 복합제제
US20100129444A1 (en) Novel Pharmaceutical Formulations of Modafinil
CZ443399A3 (cs) Terapauticky aktivní kompozice
KR100849806B1 (ko) 팽윤성 식이섬유와 리파제 억제제를 포함하는 비만 억제조성물 및 이의 제조 방법
DK177906B1 (en) Dispersible tablet
CN113509465A (zh) 一种具有抗高血压作用的组合物及其应用
AMITRIPTYLINE in partial fulfilment of the requirements for the award of degree of MASTER OF PHARMACY IN PHARMACEUTICS
Shivling Design and Evaluation of Fast Dissolving Tablets of Atenolol
KR20080048923A (ko) 소화관에의 자극성을 감소한 경구 고형 조성물
HK1061652B (en) Solid pharmaceutical formulations comprising modafinil

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: RECKITT BENCKISER HEALTHCARE (UK) LIMITED

Free format text: FORMER NAME: RECKITT AND COLMAN PRODUCTS LIMITED

FGA Letters patent sealed or granted (standard patent)